Journal
Frontiers in Medicine
Publication Date
1-1-2023
Volume
10
First Page
1090737
Document Type
Open Access Publication
DOI
10.3389/fmed.2023.1090737
Rights and Permissions
Jaeger ZJ, Raval NS, Maverakis NKA, Chen DY, Ansstas G, Hardi A and Cornelius LA (2023) Objective response to immune checkpoint inhibitor therapy in NRAS-mutant melanoma: A systematic review and meta-analysis. Front. Med. 10:1090737. doi: 10.3389/fmed.2023.1090737 © 2023 Jaeger, Raval, Maverakis, Chen, Ansstas, Hardi and Cornelius. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Jaeger, Zachary J; Raval, Neel S; Maverakis, Natalia K A; Chen, David Y; Ansstas, George; Hardi, Angela; and Cornelius, Lynn A, "Objective response to immune checkpoint inhibitor therapy in NRAS-mutant melanoma: A systematic review and meta-analysis." Frontiers in Medicine. 10, 1090737 (2023).
https://digitalcommons.wustl.edu/oa_4/2596
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
